PT-141 / Oxytocin

A nasal combination studied for desire and connection, pairing PT-141 with oxytocin.

$350USD

10mg + 5mg · nasal spray

This combination is studied for complementary CNS receptor pathway engagement. PT-141 targets melanocortin MC3R and MC4R receptors in neural circuits associated with limbic signaling, while oxytocin interacts with hypothalamic and limbic oxytocinergic receptors linked to social bonding and emotional regulation research. Research suggests nasal delivery may support direct CNS access for both peptides through olfactory pathway absorption. Intended for research purposes.

Shop now ← Back to shop

+Why It Works

This combination pairs two peptides studied for complementary CNS pathways. PT-141 engages melanocortin MC3R/MC4R receptors in limbic circuits, while oxytocin interacts with hypothalamic and limbic receptors linked to bonding and emotional regulation. Nasal delivery is studied for direct CNS access through olfactory pathway absorption.

+Key Benefits

Dual CNS Pathway Engagement — Combines melanocortin and oxytocinergic signaling in one spray.
Desire & Connection Signaling — Studied for its role in limbic-circuit activity tied to intimacy.
Non-Invasive Delivery — Nasal absorption avoids injections entirely.

+Who It's For

Couples exploring connection-focused researchInterested in oxytocinergic and limbic signaling.

Individuals researching desire-related CNS pathwaysAs part of a broader wellness protocol.

Research Use Only. These products have not been evaluated or approved by the FDA for use as drugs, therapeutics, diagnostics, or dietary supplements, and are not intended for administration to humans or animals. No product description or mechanism-of-action information constitutes a health claim or therapeutic endorsement. Any clinical use is at the sole discretion of a licensed healthcare provider in compliance with applicable laws. Individual results may vary.